Compare Lupin with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs FRESENIUS KABI ONCO. - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN FRESENIUS KABI ONCO. LUPIN/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 47.0 22.1 212.4% View Chart
P/BV x 4.3 3.1 138.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 LUPIN   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    LUPIN
Mar-20
FRESENIUS KABI ONCO.
Mar-13
LUPIN/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs882176 501.3%   
Low Rs50579 643.3%   
Sales per share (Unadj.) Rs339.437.7 900.6%  
Earnings per share (Unadj.) Rs-5.95.1 -116.8%  
Cash flow per share (Unadj.) Rs15.56.7 230.1%  
Dividends per share (Unadj.) Rs6.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs276.742.5 650.5%  
Shares outstanding (eoy) m453.00158.23 286.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.03.4 60.5%   
Avg P/E ratio x-116.625.0 -466.8%  
P/CF ratio (eoy) x44.818.9 236.9%  
Price / Book Value ratio x2.53.0 83.8%  
Dividend payout %-100.90-   
Avg Mkt Cap Rs m314,20120,135 1,560.5%   
No. of employees `00018.31.2 1,588.7%   
Total wages/salary Rs m29,868703 4,247.5%   
Avg. sales/employee Rs Th8,400.65,176.2 162.3%   
Avg. wages/employee Rs Th1,632.0610.4 267.4%   
Avg. net profit/employee Rs Th-147.2699.6 -21.0%   
INCOME DATA
Net Sales Rs m153,7485,963 2,578.4%  
Other income Rs m4,83818 26,875.6%   
Total revenues Rs m158,5855,981 2,651.5%   
Gross profit Rs m24,8491,430 1,737.6%  
Depreciation Rs m9,702258 3,762.0%   
Interest Rs m3,630-26 -13,960.8%   
Profit before tax Rs m16,3551,216 1,344.7%   
Minority Interest Rs m40-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m-7,521-68 11,043.6%   
Tax Rs m11,571342 3,381.4%   
Profit after tax Rs m-2,694806 -334.3%  
Gross profit margin %16.224.0 67.4%  
Effective tax rate %70.828.1 251.5%   
Net profit margin %-1.813.5 -13.0%  
BALANCE SHEET DATA
Current assets Rs m154,1325,102 3,021.3%   
Current liabilities Rs m92,2522,385 3,867.4%   
Net working cap to sales %40.245.6 88.4%  
Current ratio x1.72.1 78.1%  
Inventory Days Days82150 54.7%  
Debtors Days Days129113 114.1%  
Net fixed assets Rs m89,0825,148 1,730.4%   
Share capital Rs m906158 572.7%   
"Free" reserves Rs m124,4616,556 1,898.5%   
Net worth Rs m125,3676,732 1,862.3%   
Long term debt Rs m17,933952 1,883.3%   
Total assets Rs m249,83910,388 2,405.1%  
Interest coverage x5.5-45.8 -12.0%   
Debt to equity ratio x0.10.1 101.1%  
Sales to assets ratio x0.60.6 107.2%   
Return on assets %0.47.5 5.0%  
Return on equity %-2.112.0 -17.9%  
Return on capital %8.714.6 59.8%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m51,4505,298 971.2%   
Fx outflow Rs m19,4701,772 1,098.6%   
Net fx Rs m31,9803,525 907.1%   
CASH FLOW
From Operations Rs m14,6881,274 1,152.8%  
From Investments Rs m11,070-1,204 -919.3%  
From Financial Activity Rs m-8,906-196 4,541.5%  
Net Cashflow Rs m16,853-126 -13,343.2%  

Share Holding

Indian Promoters % 46.6 0.0 -  
Foreign collaborators % 0.2 81.0 0.2%  
Indian inst/Mut Fund % 11.3 0.3 3,766.7%  
FIIs % 31.9 9.6 332.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 9.1 111.0%  
Shareholders   98,259 42,599 230.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  WOCKHARDT  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare LUPIN With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


May 6, 2021 (Close)

TRACK LUPIN

LUPIN - FDC COMPARISON

COMPARE LUPIN WITH

MARKET STATS